Panagiotis Garantziotis

Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus

Lennard Ostendorf, Marie E. Burns, Pawel Durek et al. · New England Journal of Medicine · 2020 · 293 citations

Immunology, Pathology, Plasma Cells +16

High Comorbidity Burden in Patients with SLE: Data from the Community-Based Lupus Registry of Crete

Irini Gergianaki, Panagiotis Garantziotis, Christina Adamichou et al. · Journal of Clinical Medicine · 2021 · 55 citations · Full text

Novel aspects of regulatory T cell dysfunction as a therapeutic target in giant cell arteritis

Ignatius Ryan Adriawan, Faranaz Atschekzei, Oliver Dittrich‐Breiholz et al. · Annals of the Rheumatic Diseases · 2021 · 28 citations · Full text

Molecular Taxonomy of Systemic Lupus Erythematosus Through Data-Driven Patient Stratification: Molecular Endotypes and Cluster-Tailored Drugs

Panagiotis Garantziotis, Dimitrios Nikolakis, Stavros Doumas et al. · Frontiers in Immunology · 2022 · 25 citations · Full text

Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression

Sofia Pitsigavdaki, Myrto Nikoloudaki, Panagiotis Garantziotis et al. · Annals of the Rheumatic Diseases · 2024 · 25 citations · Full text